scholarly journals Human transitional and IgM low mature naïve B cells preserve permissive B cell receptors

Author(s):  
Zhiguo Zhang ◽  
Christopher J Jara ◽  
Mandeep Singh ◽  
Huji Xu ◽  
Christopher C Goodnow ◽  
...  
Cells ◽  
2020 ◽  
Vol 9 (6) ◽  
pp. 1448 ◽  
Author(s):  
Aurélien Pélissier ◽  
Youcef Akrout ◽  
Katharina Jahn  ◽  
Jack Kuipers  ◽  
Ulf Klein  ◽  
...  

Germinal centers (GCs) are specialized compartments within the secondary lymphoid organs where B cells proliferate, differentiate, and mutate their antibody genes in response to the presence of foreign antigens. Through the GC lifespan, interclonal competition between B cells leads to increased affinity of the B cell receptors for antigens accompanied by a loss of clonal diversity, although the mechanisms underlying clonal dynamics are not completely understood. We present here a multi-scale quantitative model of the GC reaction that integrates an intracellular component, accounting for the genetic events that shape B cell differentiation, and an extracellular stochastic component, which accounts for the random cellular interactions within the GC. In addition, B cell receptors are represented as sequences of nucleotides that mature and diversify through somatic hypermutations. We exploit extensive experimental characterizations of the GC dynamics to parameterize our model, and visualize affinity maturation by means of evolutionary phylogenetic trees. Our explicit modeling of B cell maturation enables us to characterise the evolutionary processes and competition at the heart of the GC dynamics, and explains the emergence of clonal dominance as a result of initially small stochastic advantages in the affinity to antigen. Interestingly, a subset of the GC undergoes massive expansion of higher-affinity B cell variants (clonal bursts), leading to a loss of clonal diversity at a significantly faster rate than in GCs that do not exhibit clonal dominance. Our work contributes towards an in silico vaccine design, and has implications for the better understanding of the mechanisms underlying autoimmune disease and GC-derived lymphomas.


PLoS ONE ◽  
2015 ◽  
Vol 10 (7) ◽  
pp. e0132571 ◽  
Author(s):  
Lenka Plzakova ◽  
Zuzana Krocova ◽  
Klara Kubelkova ◽  
Ales Macela

Immunity ◽  
2008 ◽  
Vol 29 (6) ◽  
pp. 912-921 ◽  
Author(s):  
Fabian Köhler ◽  
Eva Hug ◽  
Cathrin Eschbach ◽  
Sonja Meixlsperger ◽  
Elias Hobeika ◽  
...  

2013 ◽  
Vol 88 (5) ◽  
pp. 2645-2657 ◽  
Author(s):  
A. T. McGuire ◽  
J. A. Glenn ◽  
A. Lippy ◽  
L. Stamatatos ◽  
R. W. Doms

2000 ◽  
Vol 175 (1) ◽  
pp. 33-46 ◽  
Author(s):  
Fritz Melchers ◽  
Edwin ten Boekel ◽  
Thomas Seidl ◽  
Xian Chu Kong ◽  
Tamotsu Yamagami ◽  
...  

Immunology ◽  
1996 ◽  
Vol 88 (4) ◽  
pp. 593-599 ◽  
Author(s):  
T. NAKAMURA ◽  
M. KOYAMA ◽  
A. YONEYAMA ◽  
M. HIGASHIHARA ◽  
T. KAWAKAMI ◽  
...  

2019 ◽  
Author(s):  
Theresa Pesch ◽  
Lucia Bonati ◽  
William Kelton ◽  
Cristina Parola ◽  
Roy A Ehling ◽  
...  

AbstractImmune cell therapies based on the integration of synthetic antigen receptors provide a powerful strategy for the treatment of diverse diseases, most notably retargeting T cells engineered to express chimeric antigen receptors (CAR) for cancer therapy. In addition to T lymphocytes, B lymphocytes may also represent valuable immune cells that can be engineered for therapeutic purposes such as protein replacement therapy or recombinant antibody production. In this article, we report a promising concept for the molecular design, optimization and genomic integration of a novel class of synthetic antigen receptors, chimeric B cell receptors (CBCR). We initially optimized CBCR expression and detection by modifying the extracellular surface tag, the transmembrane regions and intracellular signaling domains. For this purpose, we stably integrated a series of CBCR variants into immortalized B cell hybridomas using CRISPR-Cas9. Subsequently, we developed a reliable and consistent pipeline to precisely introduce cassettes of several kilobases size into the genome of primary murine B cells, again via CRISPR-Cas9 induced HDR. Finally, we were able to show the robust surface expression and antigen recognition of a synthetic CBCR in primary B cells. We anticipate that CBCRs and our approach for engineering primary B cells will be a valuable tool for the advancement of future B cell-based immune therapies.


2018 ◽  
Author(s):  
Aleah D. Roberts ◽  
Thaddeus M. Davenport ◽  
Andrea M. Dickey ◽  
Regina Ahn ◽  
Kem A. Sochacki ◽  
...  

ABSTRACTB lymphocytes play a critical role in adaptive immunity. Upon antigen binding, B cell receptors (BCR) cluster on the plasma membrane and are internalized by endocytosis. In this process, B cells capture diverse antigens in various contexts and concentrations. However, it is unclear whether the mechanism of BCR endocytosis changes in response to these factors. Here, we studied the mechanism of soluble antigen-induced BCR clustering and internalization in a cultured human B cell line using correlative super resolution fluorescence and platinum replica electron microscopy. First, by visualizing nanoscale BCR clusters, we provide direct evidence that BCR cluster size increases with F(ab’)2 concentration. Next, we show that the physical mechanism of internalization switches in response to BCR cluster size. At low concentrations of antigen, B cells internalize small BCR clusters by classical clathrin-mediated endocytosis. At high antigen concentrations, when clusters size increases beyond the size of a single clathrin coated pit, B cells retrieve receptor clusters using large invaginations of the plasma membrane capped with clathrin. At these sites, we observed early and sustained recruitment of actin and an actin polymerizing protein FCHSD2. We further show that actin recruitment is required for the efficient generation of these novel endocytic carriers and for their capture into the cytosol. We propose that in B cells, the mechanism of endocytosis switches to accommodate large receptor clusters formed when cells encounter high concentrations of soluble antigen. This mechanism is regulated by the organization and dynamics of the cortical actin cytoskeleton.


Sign in / Sign up

Export Citation Format

Share Document